NEO:NASDAQ
NeoGenomics, Inc.
$18.50
arrow_upward
+0.16%(+0.030) 1D
Okt 5, 9:46:23 AM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa NEO...
Buksan
$18.48
Mataas
$18.58
Mababa
$18.28
Mkt. cap
2.38B
Avg. na dami
2.03M
Dami
15.64K
Mataas nang 52-wk
$20.05
Mababa nang 52-wk
$7.06
EPS
-$0.40
Beta
1.79
Mga natitirang share
128.48M
Bilang ng mga empleyado
2K
Buksan
$18.48
Mataas
$18.58
Mababa
$18.28
Mkt. cap
2.38B
Avg. na dami
2.03M
Dami
15.64K
Mataas nang 52-wk
$20.05
Mababa nang 52-wk
$7.06
EPS
-$0.40
Beta
1.79
Mga natitirang share
128.48M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
AD HOC NEWS
·
1 araw ang nakalipas
NeoGenomics stock gained 3.88 percent after Q2 earnings beat
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
Tungkol sa NeoGenomics, Inc.
CEOChristopher M. Smith
Mga Empleyado2.5K
Itinatag2002
HeadquartersFort Myers, Florida, Estados Unidos
SektorHealth care provider
Websiteneogenomics.com